Medicaid asset test would strip coverage from millions with modest savings

What it does

This bill requires states to impose an asset test on Medicaid expansion enrollees starting in 2029, disqualifying individuals whose resources exceed $10,000 (or $20,000 if married). The threshold rises every four years with inflation. States retain flexibility to set lower limits or exclude certain assets, and the bill explicitly protects federal matching funds for states that implement these tests.

Why we flagged it

The bill's functional purpose is to narrow Medicaid eligibility for the expansion population by introducing an asset/resources test, reducing enrollment and shifting costs to beneficiaries and states. The title 'Equal Standards Act' obscures this restrictive mechanism by implying parity or fairness, when the actual effect is to impose a new barrier not previously required.

What the text implies

• The $10,000 asset threshold is substantially lower than SSI limits (~$2,000 for individuals) but will disqualify working poor with modest savings, used vehicles, or small home equity. States may exclude certain assets, but the bill does not mandate such exclusions, creating a patchwork of coverage loss.
• The bill protects federal matching funds (FMAP) for states that implement the test, meaning states face no federal penalty for disenrolling expansion beneficiaries—a perverse incentive to aggressively apply the test to reduce state Medicaid costs.
• Effective date of January 1, 2029 gives states 2.5 years to implement, but the bill does not require notice to current beneficiaries or transition periods, risking sudden disenrollment for individuals unaware of the new test.
• The 'state flexibility' language (allowing states to set lower thresholds or exclude assets) creates a race-to-the-bottom dynamic where states compete to restrict eligibility, fragmenting coverage across the country.
• Pharmaceutical, dialysis, and hospital sectors (mapped stocks) may see reduced utilization among disenrolled Medicaid beneficiaries, shifting care to emergency departments or uncompensated care, which may increase bad debt write-offs.

Who it affects

Millions of low-income Medicaid expansion beneficiaries will lose coverage or face barriers to enrollment due to modest asset holdings (savings, vehicles, home equity exclusions vary by state). This disproportionately harms working poor and elderly individuals who have accumulated small emergency reserves, while providing no offsetting public benefit.

Who stands to gain

• state governments (reduced Medicaid expenditures)
• pharmaceutical companies (reduced Medicaid volume offset by higher private-pay prices)
• dialysis providers (reduced Medicaid patient volume)

Named in the bill

Social Security Act Section 1902, Section 1613 (SSI resource definitions), Medicaid expansion population, FMAP (Federal Medical Assistance Percentage), Consumer Price Index for All Urban Consumers, Bristol Myers Squibb (BMY), Guardant Health (GH), Pfizer (PFE), DaVita (DVA), Johnson & Johnson (JNJ)

Where it stands

• Jun 18, 2026 — Introduced · Congress.gov: “Introduced in House”
• Jun 18, 2026 — Referred to House Committee on Energy and Commerce · Congress.gov: “Referred to the House Committee on Energy and Commerce”

Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.